Palm tocotrienols and cancer

Phytopharmaceuticals in Cancer Chemoprevention

Volumn , Issue , 2004, Pages 481-490

  Nesaretnam, Kalanithi ^a  

^a MALAYSIAN PALM OIL BOARD   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67349129473     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (36)

1. IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), Nomenclature of tocopherols and related compounds: recommendations 1981, Eur. J. Biochem., 123, 473-475, 1982.
2. Therialut, A., Chao, Q., Wang, A., Gapor, A., and Adeli, K., Tocotrienol: a review of its therapeutic potential, Clin. Biochem., 32, 309-319, 1999.
3. Sundram, K. and Gapor, A., Vitamin E from palm oil: its extraction and nutritional properties, Lipid Technol., 4, 137-141, 1996.
4. Sokal, R.R., Vitamin E deficiency and neurological disorders, in Vitamin E in Health and Disease, Packer, L. and Fuchs, J., Eds., Marcel Dekker, New York, 1993, pp. 815-849.
5. Serbinova, E., Kagan, V., Han, D., and Packer, L., Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol, Free Radical Biol. Med., 10, 263-275, 1991.
6. Suzuki, Y.J., Tsuchiya, M., and Wassall, S.R., Structural and dynamic membrane properties of αtocopherol and α-tocotrienol: implications to the molecular mechanism of their antioxidant potency, Biochemistry, 32, 10692-10696, 1993.
7. Kayden, H.J. and Traber, M.G., Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans, J. Lipid Res., 34, 343-358, 1993.
8. Yap, S.P., Kuen, K.H., and Wong, J.W., Pharmacokinetics and bioavailability of alpha-, gamma- and delta-tocotrienols under different food status, J. Pharm. Pharmacol., 1, 67-71, 2001.
9. Brigelius-Flohe, R. and Traber, M.G., Vitamin E: function and metabolism, FASEB J., 13, 1145-1155, 1999.
10. Lodge, J.K., Ridlington, J., Leonard, S., Vaule, H., and Traber, M.G., α- and γ-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine, Lipids, 36, 43-48, 2001.
11. Hayes, K.C., Pronczuk, A., and Liang, J.S., Differences in the plasma transport and tissue concentrations of tocopherols and tocotrienols: observations in humans and hamsters, Proc. Soc. Exp. Biol. Med., 202, 353-359, 1993.
12. Traber, M.G., Podda, M., Weber, C., Thiele, J., Rallis, M., and Packer, L., Diet derived and topically applied tocotrienols accumulate in skin and protect the tissue against ultraviolet light-induced oxidative stress, Asia Pac. J. Clin. Nutr., 6, 63-67, 1997.
13. Kamal-eldin, A. and Appelqvist, L.A., The chemistry and antioxidant properties of tocopherols and tocotreinols, Lipids, 31, 671-701, 1996.
14. Niki, E., Kawakami, A., Satio, M., Yamamoto, Y., Tucshiya, J., and Kamiya, Y., Effect of phytyl side chain of vitamin E on its antioxidant activity, J. Biol. Chem., 260, 2191-2196, 1985.
15. Burton, G.W. and Ingold, K.U., Vitamin E as in vitro and in vivo antioxidant, Ann. N.Y. Acad. Sci., 570, 7-22, 1989.
16. Burton, G. and Traber, M.G., Vitamin E: antioxidant activity, biokinetics and bioavailability, Ann. Rev. Nut., 10, 857-882, 1990.
17. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum, J.L., Beyond cholesterol:modification of low density lipoprotein that increases its atherogenicity, New England J. Med., 320, 915-924, 1989.
18. Burton, G.W., Joyce, A., and Ingold, K.U., Is vitamin E the only lipid soluble, chain breaking, antioxidant combination in human blood plasma and erythrocyte membranes?, Arch. Biochem. Biophys., 221, 281-290, 1983.
19. Nesaretnam, K., Devasagayam, T.P.A., Singh, B.B., and Basiron, Y., Influence of palm oil or its tocotrienol-rich fraction on the lipid peroxidation potential of rat liver mitochondria and microsomes, Biochem. Mol. Biol. Inter., 30, 159-167, 1993.
20. Kamat, J.P., Sarma, H.D., Devasagayam, T.P.A., Nesaretnam, K., and Basiron, Y., Tocotrienols from palm oil as effective inhibitors of protein oxidation and lipid peroxidation in rat liver microsomes, Mol. Cell. Biochem., 170, 131-138, 1998.
21. Kamat, J.P. and Devasagayam, T.P.A., Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria, Neuro. Lett., 195, 179-182, 1995.
22. Serbinova, E., Khwaja, S., and Catudioc, J., Palm oil vitamin E protects against ischaemia/reperfusion injury in the isolated perfused Langendorff heart, Nutr. Res., 12, S205-S215, 1996.
23. Wang, M., Dhingra, K., Hittleman, W.N., Liehr, J.G., De Andrade, M., and Li, D., Lipid peroxidationinduced putative malondialdehyde-DNA adducts in human breast tissues, Cancer Epidemiol. Biomarkers Prev., 5, 705-710, 1996.
24. Nesaretnam, K., Khor, H.T., Ganeson, J., Chong, Y.H., Sundram, K., and Gapor, A., The effect of vitamin E tocotrienols from palm oil on chemically induced mammary carcinogenesis in female rats, Nutr. Res., 12, 879-892, 1992.
25. Bundred, N.J., Prognostic and predictive factors in breast cancer, Cancer Treat. Rev., 27, 137-142, 2001.
26. Nesaretnam, K., Guthrie, N., Chambers, A.F., and Carroll, K.K., Effect of tocotrienols on the growth of human breast cancer cell line in culture, Lipids, 30, 1139-1143, 1995.
27. Carroll, K.K., Guthrie, N., Nesaretnam, K., Gapor, A., and Chambers, A.F., Anticancer properties of tocotrienols from palm oil, in Nutrition, Lipids, Health and Disease, Ong, A.S.H., Niki, E., and Packer, L., Eds., AOCS Press, pp. 117-121.
28. Nesaretnam, K., Stephen, R., Dils, R., and Darbre, P., Tocotrienols inhibit the growth of human breast cancer cells irrespectively of estrogen receptor status, Lipids, 33, 461-469, 1998.
29. Guthrie, N., Gapor, A., Chambers, A., and Caroll, K.K., Inhibition of proliferation of estrogen receptornegative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination, J. Nutr., 127, 544S-548S, 1997.
30. Sylvester, K., McIntyre, B.S., Gapor, A., and Brsiki, K.P., Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation, Cell. Prolif., 34, 347-357, 2001.
31. Wan Zurinah, W.N., Zanariah, J., San, M.M., Marzuki, A., Gapor, A., Shamaan, N.A., and Khalid, A.K., Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats, Am. J. Clin. Nutr., 53, 1076S-1081S, 1991.
32. Komiyama, K. and Yamaoka, Studies on the biological activity of tocotrienols, Chem. Pharm. Bull., 37, 1369-1371, 1991.
33. Kato, A., Yamaoka, M., Tanaka, A., Komiyama, K., and Umezawa, I., Physiological effect of tocotrienols, Yakugaku Zasshi, 34, 375-376, 1985.
34. Tan, B., Antitumour effects of palm carotenes and tocotrienols in HRS/J hairless female mice, Nutr. Res., 12, S163-S173, 1992.
35. Crowell, P.L., Chang, R.R., Ren, Z.B., Elson, C.E., and Gould, M.N., Selective inhibition of isoprenylation of 21-26 kDA proteins by the anticarcinogen d-limonene and its metabolites, J. Biol. Chem., 266, 1769-1785, 1991.
36. Elson, C.E. and Yu, S.G., The chemoprevention of cancer by mevanolate-derived constituents of fruits and vegetables, J. Nutr., 124, 607-614, 1994.